Pharmaceutical trends and the role of MES

Published: 26-Apr-2017
Media Manufacturing

With trends in the pharmaceutical industry continuously evolving, manufacturers are under increasing pressure to keep pace and adapt their operations to meet changing needs

You need to be a subscriber to read this article.
Click here to find out more.

In this article, Christian Fortunel, Vice President of LZ Lifescience, discusses today’s most significant market trends, including continuous manufacturing, the increased demand for individualised medicines, patient-centricity and globalisation, as well as FDA’s focus on quality, and addresses the advantages that manufacturing execution systems (MES) bring in meeting the complexities of these developments.

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.

Subscribe now Already a subscriber? Sign in here.
See more

You may also like

Manufacturing

IDA Ireland releases whitepaper on the future of biopharma manufacturing in Ireland

Read more
The report highlights details on Ireland's geopolitical stability, its high regulatory standards and how the country is forging ahead as a leader in the advanced therapy and next-gen biologics sector

Trending Articles

  1. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
  2. Guardtech reshaping the landscape of UK cleanroom facility exports with Cleancube The East Anglian controlled environment construction specialists reached new horizons with their ground-breaking Biotech facility for Oxitec in Djibouti
  3. Updated MHRA GMP certificates strengthen Piramal’s bioconjugates capabilities at Grangemouth Certification renewal supports clinical and commercial ADC development and manufacturing
  4. Aenova appoints Alexandre Pasini as Chief Operating Officer Aenova announces the appointment of Alexandre Pasini as Chief Operating Officer (COO), effective November 1, 2025
  5. CHEMUK EXPO Discover CHEMUK – The UK’s Premier Chemical Industry Expo – a cornerstone event for the chemicals, laboratory, and process engineering sectors

Upcoming event

Pharmapack

21–22 January 2026 | Exhibition | Paris, France See all

You may also like

Manufacturing

IDA Ireland releases whitepaper on the future of biopharma manufacturing in Ireland

The report highlights details on Ireland's geopolitical stability, its high regulatory standards and how the country is forging ahead as a leader in the advanced therapy and next-gen biologics sector
Manufacturing

Thermo Fisher Scientific doubles down on investment in Asia

New and expanded Bioprocess Design Centres will provide local expertise, advanced technologies and tailored support for biopharma innovators throughout the region
Manufacturing

Buckland Group launches Quvara Medical after acquiring Becton Dickinson’s Swindon site to boost UK-EU medical manufacturing

The acquisition establishes Quvara Medical as a new UK- and EU-based CMO offering GMP- and ISO-certified, high-volume manufacturing services to pharma and medtech clients
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Top trends in industrial monitoring and control

Monitoring and control advancements are central to driving productivity, resilience and profitability in every enterprise, reports Andy Graham, Solutions Manager at SolutionsPT
Manufacturing

Thermo Fisher launches general purpose centrifuges with natural refrigerant cooling

New X and S Series models offer high performance with reduced environmental impact
Manufacturing

Rentschler Biopharma and Coriolis Pharma partner to deliver integrated biopharma development and manufacturing solutions

The German-based CDMO and CRDO will offer unified formulation-to-manufacturing services to accelerate biologics development. The collaboration aims to cut complexity, timelines and risk for global biopharma clients
You need to be a subscriber to read this article.
Click here to find out more.
Personal Protection

Revolutionising temperature control: the benefits of thermal insulated coatings in the pharmaceutical industry

Insulation is safety critical in pharmaceutical factories, where hot pipes and equipment pose a significant burn risk to workers. Yet traditional approaches often fall short in terms of durability and longevity … and can be expensive to install and maintain
Subscribe now